Pyrazole-Thiazole Core-Containing Analogs Exhibit Adjunctive Activity with Meropenem against Carbapenem-Resistant Enterobacteriaceae (CRE)

被引:3
|
作者
Kim, Chungsik [1 ]
Kassu, Mintesinot [1 ]
Smith, Kenneth P. [3 ]
Kirby, James E. [3 ]
Manetsch, Roman [1 ,2 ]
机构
[1] Northeastern Univ, Dept Chem & Chem Biol, 360 Huntington Ave, Boston, MA 02115 USA
[2] Northeastern Univ, Dept Pharmaceut Sci, 360 Huntington Ave, Boston, MA 02115 USA
[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
antibacterial activity; carbapenem-resistant enterobacteriaceae; adjunctive activity; meropenem; GRAM-NEGATIVE BACTERIA; BLOOD-STREAM; INFECTIONS; DESIGN; COMBINATION; DERIVATIVES; INHIBITORS;
D O I
10.1002/cmdc.202100321
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pyrazole-thiazole core-containing compound KP-40 and 20 novel derivatives were designed and synthesized through traditional SAR analysis. These molecules displayed adjunctive activity with meropenem against Gram-negative bacteria evidenced by a range of fractional inhibitory concentration (FIC=0.5-0.25) and minimum adjunctive concentration (MAC=128-32 mu M) values. Of this series of molecules, four compounds displayed notable adjunctive potential, with FIC and MAC values of 0.25 and 32 mu M, respectively. Moreover, the solubility of these compounds was improved to an acceptable range. Further analysis using our "in house" permeation and efflux multi parameter optimization (PEMPO) algorithm revealed key physicochemical properties that may be critical for the development of active Gram-negative antibacterials. Taking PEMPO scores into consideration prior to executing synthesis of analogs may be a simple, yet rapid and effective strategy that can be used in conjunction with traditional SAR approaches to aid in the design of potent Gram-negative antibacterials.
引用
收藏
页码:2775 / 2780
页数:6
相关论文
共 50 条
  • [21] Activity of BAL30072 alone or combined with -lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters
    Mushtaq, Shazad
    Woodford, Neil
    Hope, Russell
    Adkin, Rachael
    Livermore, David M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (07) : 1601 - 1608
  • [22] Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in an In Vitro Hollow-Fiber Model
    Sabet, Mojgan
    Tarazi, Ziad
    Rubio-Aparicio, Debora
    Nolan, Thomas G.
    Parkinson, Jonathan
    Lomovskaya, Olga
    Dudley, Michael N.
    Griffith, David C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (02)
  • [23] Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC
    Barnes, Melissa D.
    Taracila, Magdalena A.
    Good, Caryn E.
    Bajaksouzian, Saralee
    Rojas, Laura J.
    van Duin, David
    Kreiswirth, Barry N.
    Jacobs, Michael R.
    Haldimann, Andreas
    Papp-Wallace, Krisztina M.
    Bonomo, Robert A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (08)
  • [24] Biocompatibility, cytotoxicity and antibacterial effects of meropenem-loaded mesoporous silica nanoparticles against carbapenem-resistant Enterobacteriaceae
    Memar, Mohammad Yousef
    Yekani, Mina
    Ghanbari, Hadi
    Shahi, Shahriar
    Sharifi, Simin
    Maleki Dizaj, Solmaz
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2020, 48 (01) : 1354 - 1361
  • [25] Dithiocarbamates combined with copper for revitalizing meropenem efficacy against NDM-1-producing Carbapenem-resistant Enterobacteriaceae
    Chen, Cheng
    Yang, Ke-Wu
    Zhai, Le
    Ding, Huan-Huan
    Chigan, Jia-Zhu
    BIOORGANIC CHEMISTRY, 2022, 118
  • [26] Staggering the administration of polymyxin B and meropenem in time-kill against carbapenem-resistant Enterobacteriaceae exhibiting a wide range of meropenem MICs
    Kulengowski, Brandon
    Clark, Justin A.
    Burgess, David S.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 93 (03) : 261 - 264
  • [27] Biological studies of the activity of Manuka honey against Carbapenem-resistant Enterobacterales (CRE) bacteria
    Bukhari, Mamdouh A.
    Qamash, Razaz A.
    Bulkhi, Rasha A.
    Bifari, Jehad A.
    Bakhsh, Omar S.
    Hawsawi, Khalid O.
    Matuure, Ehab Y.
    Sulaimani, Kamil A.
    Hakim, Ashwaq T.
    Mujahid, Maher S.
    SAUDI MEDICAL JOURNAL, 2024, 45 (09) : 876 - 881
  • [28] Estimating the Size of the US Market for New Antibiotics with Activity against Carbapenem-Resistant Enterobacteriaceae
    Clancy, Cornelius J.
    Nguyen, M. Hong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (12)
  • [29] Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
    Livermore, D. M.
    Mushtaq, S.
    Warner, M.
    Zhang, J-C
    Maharjan, S.
    Doumith, M.
    Woodford, N.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (01) : 48 - 53
  • [30] Activity of Meropenem-Vaborbactam in Mouse Models of Infection Due to KPC-Producing Carbapenem-Resistant Enterobacteriaceae
    Sabet, Mojgan
    Tarazi, Ziad
    Nolan, Thomas
    Parkinson, Jonathan
    Rubio-Aparicio, Debora
    Lomovskaya, Olga
    Dudley, Michael N.
    Griffith, David C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)